Jane Street’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$605K Sell
20,800
-39,300
-65% -$1.04M ﹤0.01% 7580
2026
Q2
$1.08M Buy
60,100
+48,200
+405% +$745K ﹤0.01% 6380
2026
Q1
$165K Buy
11,900
+1,800
+18% +$25.3K ﹤0.01% 10305
2025
Q4
$122K Buy
+10,100
New +$137K ﹤0.01% 10070
2024
Q2
– Sell
-78,100
Closed -$222K – 9424
2024
Q1
$222K Sell
78,100
-1,865,000
-96% -$24.4M ﹤0.01% 8197
2023
Q4
$28.6M Buy
1,943,100
+962,500
+98% +$14.8M 0.01% 1029
2023
Q3
$18M Buy
980,600
+6,400
+0.7% +$135K 0.01% 1231
2023
Q2
$21M Buy
974,200
+318,000
+48% +$8.59M 0.01% 1197
2023
Q1
$19.3M Buy
656,200
+33,900
+5% +$1.18M 0.01% 1073
2022
Q4
$23M Buy
622,300
+317,400
+104% +$11.3M 0.01% 938
2022
Q3
$8.58M Buy
304,900
+292,000
+2,264% +$7.28M ﹤0.01% 1915
2022
Q2
$248K Buy
+12,900
New +$153K ﹤0.01% 8069

Other funds holding AMLX

Jane Street's AMLX Position: Q3 2026 in Review

Jane Street increased its Amylyx Pharmaceuticals (AMLX) stake by 145% in Q3 2026, buying an estimated $11.5M and bringing the position to 735,231 shares worth $21.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2028.

Jane Street first reported a position in AMLX in Q1 2022 and has held it in 16 quarters since. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • Jane Street held 735,231 shares of Amylyx Pharmaceuticals worth $21.4M as of Q3 2026.
  • Jane Street bought 435,666 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $11.5M.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #2028 holding.
  • Jane Street first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
  • 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.